Bayer commissions external law firm to investigate Monsanto's stakeholder mapping project and reaffirms its commitment to transparency and fair dealings with all stakeholders

U.S. FDA accepts new drug application and grants priority review for darolutamide

Study reaffirms safety and efficacy profile of Xarelto™ for the prevention of stroke in patients with atrial fibrillation

First results from RELOADED, an observational study in the EU, indicate that non-vitamin-K oral anticoagulants (NOACs) like Xarelto provide ...

Bayer’s Supervisory Board unanimously stands behind Board of Management

“We made great progress – both operationally and strategically”

Bayer now the leader in agriculture / Lawsuits and first verdicts concerning glyphosate weigh on company / Sales and earnings increased in 2018 ...

Bayer: strong operational start to the year

Group sales increase 4.1 percent (Fx & portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros ...

Bayer Animal Health and adivo sign global collaboration agreement

Bayer to strengthen its portfolio of products for companion animals ...

Bayer and Fair Planet renew commitment to improve access to seeds in Ethiopia

Five-year renewal aims to improve food and nutrition security, provide economic opportunities for smallholder farmers in Ethiopia ...

Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares Foundations

More than 100 Bayer-owned glyphosate safety study reports accessible as Monsanto integration continues